|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.14 USD | +0.14% |
|
+1.79% | +9.79% |
| 01-13 | Guardant Health, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 03:45 PM | |
| 01-12 | Guardant Health shares up 2.4% after preliminary Q4 revenue beats estimates | RE |
| Capitalization | 14.45B 12.46B 11.6B 10.79B 20.1B 1,311B 21.62B 133B 52.59B 625B 54.18B 53.07B 2,283B | P/E ratio 2025 * |
-36.4x | P/E ratio 2026 * | -40.4x |
|---|---|---|---|---|---|
| Enterprise value | 15.01B 12.94B 12.04B 11.21B 20.88B 1,362B 22.46B 139B 54.63B 650B 56.28B 55.12B 2,372B | EV / Sales 2025 * |
15.5x | EV / Sales 2026 * | 12.4x |
| Free-Float |
95.44% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Guardant Health, Inc.
More recommendations
More press releases
More news
| 1 day | +0.14% | ||
| 1 week | +1.79% | ||
| Current month | +9.79% | ||
| 1 month | +15.05% | ||
| 3 months | +71.31% | ||
| 6 months | +137.18% | ||
| Current year | +9.79% |
| 1 week | 103.8 |  | 115.54 |
| 1 month | 96.51 | | 115.54 |
| Current year | 97.31 | | 115.54 |
| 1 year | 34.88 | | 115.54 |
| 3 years | 15.81 | | 115.54 |
| 5 years | 15.81 | | 181.07 |
| 10 years | 15.81 | | 181.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Wiley
DFI | Director of Finance/CFO | 50 | 01/01/2013 |
AmirAli Talasaz
CEO | Chief Executive Officer | 46 | 05/08/2021 |
Helmy Eltoukhy
CEO | Chief Executive Officer | 47 | 01/01/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmy Eltoukhy
CHM | Chairman | 47 | 05/08/2021 |
AmirAli Talasaz
CHM | Chairman | 46 | 01/01/2013 |
Ian Clark
BRD | Director/Board Member | 64 | 01/12/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +12.20% | 1.22% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.14% | +1.79% | +205.89% | +260.35% | 14.45B | |
| -1.51% | -7.35% | -5.42% | +6.19% | 14.33B | |
| -1.25% | -6.07% | - | - | 7.56B | |
| -0.12% | -7.51% | -4.97% | +2.61% | 6.55B | |
| -1.79% | +2.81% | -26.77% | -42.78% | 4.67B | |
| -1.79% | -4.90% | -29.76% | +18.87% | 4.26B | |
| -0.40% | -0.57% | -8.05% | -44.92% | 3.03B | |
| -3.21% | +0.29% | +36.07% | -52.69% | 2.6B | |
| -1.23% | -0.29% | +4.57% | -17.40% | 2.51B | |
| Average | -1.24% | -2.24% | +21.45% | +16.28% | 6.66B | |
| Weighted average by Cap. | -0.98% | -2.76% | +51.42% | +65.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 970M 836M 778M 725M 1.35B 87.99B 1.45B 8.95B 3.53B 41.97B 3.64B 3.56B 153B | 1.23B 1.06B 990M 922M 1.72B 112B 1.85B 11.39B 4.49B 53.41B 4.63B 4.53B 195B |
| Net income | -384M -331M -308M -287M -534M -34.81B -574M -3.54B -1.4B -16.6B -1.44B -1.41B -60.63B | -347M -299M -278M -259M -482M -31.45B -519M -3.2B -1.26B -15B -1.3B -1.27B -54.77B |
| Net Debt | 560M 483M 449M 418M 779M 50.81B 838M 5.17B 2.04B 24.23B 2.1B 2.06B 88.49B | 822M 709M 660M 614M 1.14B 74.62B 1.23B 7.59B 2.99B 35.59B 3.08B 3.02B 130B |
More financial data
* Estimated data
Employees
2,010
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 112.14 $ | +0.14% | 2,120,492 |
| 15/01/26 | 111.98 $ | +3.11% | 1,546,704 |
| 14/01/26 | 108.60 $ | +1.60% | 1,390,354 |
| 13/01/26 | 106.89 $ | -0.63% | 1,511,152 |
| 12/01/26 | 107.57 $ | -2.36% | 2,358,490 |
Delayed Quote Nasdaq, January 17, 2026 at 12:00 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
112.14USD
Average target price
121.19USD
Spread / Average Target
+8.07%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition